AJANTA PHARMA PHILIPPINES INC — Febuxostat Importer Profile
Pharmaceutical Importer · #2 buyer for Febuxostat · $1.2M import value · 25 shipments · PHILIPPINES · DGFT Verified
AJANTA PHARMA PHILIPPINES INC is the #2 importer of Febuxostat from India with $1.2M in import value and 25 verified shipments. AJANTA PHARMA PHILIPPINES INC holds a 2.6% market share in Febuxostat imports based in PHILIPPINES. The company sources from 1 verified supplier across 20 formulations shipped to 1 country. Overall, AJANTA PHARMA PHILIPPINES INC imports 7 pharmaceutical products worth $5.3M across 5 therapeutic categories.
AJANTA PHARMA PHILIPPINES INC — Febuxostat Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Febuxostat to AJANTA PHARMA PHILIPPINES INC?
Verified from 25 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AJANTA PHARMA LIMITED | $1.2M | 25 | 100.0% |
AJANTA PHARMA PHILIPPINES INC sources Febuxostat from 1 verified Indian supplier based on 25 customs records. The primary supplier is AJANTA PHARMA LIMITED accounting for 100.0% of imports.
How Does AJANTA PHARMA PHILIPPINES INC Compare to Nearest Febuxostat Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | UNILAB INC | PHILIPPINES | $1.9M | 39 | $50.0K |
| 2 | AJANTA PHARMA PHILIPPINES INC ★ | PHILIPPINES | $1.3M | 25 | $50.0K |
| 4 | J. KNIPPER & COMPANY, | UNITED STATES | $1.1M | 22 | $50.0K |
| 3 | MULTICARE PHARMACEUTICALS | PHILIPPINES | $1.0M | 20 | $50.0K |
AJANTA PHARMA PHILIPPINES INC ranks #2 among 421 Febuxostat importers from India. Average shipment value of $50.0K compared to the market average of $26.8K. The closest competitors by value are UNILAB INC and J. KNIPPER & COMPANY,.
Where Does AJANTA PHARMA PHILIPPINES INC Import Febuxostat To?
Destination countries from 25 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $1.2M | 25 | 100.0% |
AJANTA PHARMA PHILIPPINES INC imports Febuxostat to 1 country. The primary destination is PHILIPPINES receiving 100.0% of shipments worth $1.2M.
What Febuxostat Formulations Does AJANTA PHARMA PHILIPPINES INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| ATENURIX 40[105297PACKX3X10=3158910 TABS]EACH FILM COATED TAB CONT:FEBUXOSTAT 40MG] | $150.0K | 3 |
| ATENURIX TAB 20MG [52176 X 3 X 10 = 1565280 TABLETS] [EACH FILM COATED TABLET CONTAINS : FEBUXOSTAT 20 MGNOS | $148.4K | 3 |
| ATENURIX TAB 20MG[26112PACKx3x10=783360TABS]EACH FILM COATED TAB CONT:FEBUXOSTAT 20 MG | $100.0K | 2 |
| ATENURIX 40 98770PACKx3x10 2963 100 TABS EACH FILM COATED TABLET CONTAINS FEBUXOSTAT 40MG | $50.0K | 1 |
| ATENURIX 40 110304PACKx3x10 3309120 TABS EACH FILM COATED TABS CONT FEBUXOSTAT40MG | $50.0K | 1 |
| ATENURIX TAB 20MG[26352PACKx3x10=790560TABLETS][EACH FILM COATED TABLET CONTAINS : FEBUXOSTAT 20 MG | $50.0K | 1 |
| ATENURIX 40[117504PACKx3x10=3525120 TABLETS][EACH FILM COATED TABLET CONTAINS :FEBUXOSTAT 40MG] | $50.0K | 1 |
| ATENURIX TAB 80 MG[28272PACKx3x10=848160TABS][EACH FILM COATED TAB CONT:FEBUXOSTAT ...... 80] | $50.0K | 1 |
| ATENURIX 40[218784PACKx3x10=6563520 TABLETS][EACH FILM COATED TABLET CONTAINS :FEBUXOSTAT 40MG] | $50.0K | 1 |
| ATENURIX TAB 80 MG [28704 X 3 X 10 = 861120 TABLETS] [EACH FILM COATED TABLET CONTAINS : FEBUXOSTAT ...... 80] | $50.0K | 1 |
AJANTA PHARMA PHILIPPINES INC imports 20 distinct Febuxostat formulations from India. The top formulation is ATENURIX 40[105297PACKX3X10=3158910 TABS]EACH FILM COATED TA with 3 shipments worth $150.0K.
Who Are the Top Buyers of Febuxostat from India and How Much Does AJANTA PHARMA PHILIPPINES INC Import?
India exported $11.3M worth of Febuxostat through 3,494 shipments from 182 suppliers to 91 countries, serving 421 buyers globally. AJANTA PHARMA PHILIPPINES INC imports $1.2M of this total, accounting for 2.6% of India's Febuxostat exports with 25 shipments from PHILIPPINES. This is verified from 25 customs shipment records covering 20 distinct formulations.
What Is the Average Order Value for AJANTA PHARMA PHILIPPINES INC's Febuxostat Imports?
AJANTA PHARMA PHILIPPINES INC's average Febuxostat order value is $49.9K per consignment, based on 25 shipments totaling $1.2M. AJANTA PHARMA PHILIPPINES INC is based in PHILIPPINES and ranks #2 among all Febuxostat importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Febuxostat to AJANTA PHARMA PHILIPPINES INC?
AJANTA PHARMA PHILIPPINES INC sources Febuxostat from 1 verified Indian supplier: AJANTA PHARMA LIMITED ($1.2M, 100.0%). This is based on 25 customs records.
How Does AJANTA PHARMA PHILIPPINES INC Compare to Other Febuxostat Importers?
AJANTA PHARMA PHILIPPINES INC ranks #2 among 421 Febuxostat importers from India with a 2.6% market share. The top 3 importers are UNILAB INC ($1.9M), AJANTA PHARMA PHILIPPINES INC ($1.3M), J. KNIPPER & COMPANY, ($1.1M). AJANTA PHARMA PHILIPPINES INC processed 25 shipments from PHILIPPINES.
What Other Lipid & Metabolism Products Does AJANTA PHARMA PHILIPPINES INC Import?
AJANTA PHARMA PHILIPPINES INC also imports these lipid & metabolism products. Each links to the detailed product page.
About AJANTA PHARMA PHILIPPINES INC
AJANTA PHARMA PHILIPPINES INC imports 7 products worth $5.3M. Beyond Febuxostat, top products include Cetirizine, Pioglitazone, Montelukast, Glimepiride, Fenofibrate. View the complete AJANTA PHARMA PHILIPPINES INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Febuxostat — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AJANTA PHARMA PHILIPPINES INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AJANTA PHARMA PHILIPPINES INC's capped import value divided by total capped export value for Febuxostat across all Indian exporters.
- 5.Verified Records: This page is backed by 25 individual customs records matching AJANTA PHARMA PHILIPPINES INC importing Febuxostat, covering 20 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 91+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Febuxostat Import Data for AJANTA PHARMA PHILIPPINES INC
Access order-level details, pricing data, supplier connections, and competitive analysis for AJANTA PHARMA PHILIPPINES INC's Febuxostat imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AJANTA PHARMA PHILIPPINES INC
Full Company Profile →
7 products · $5.3M total trade · 5 categories
AJANTA PHARMA PHILIPPINES INC × Febuxostat
Verified from customs records
Company Overview
Top Products by AJANTA PHARMA PHILIPPINES INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AJANTA PHARMA PHILIPPINES INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Febuxostat. For current order-level data, contact TransData Nexus.